Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Anti-idiotype antibodies may explain the long-term effects of COVID-19

With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field. Researchers are working to find effective vaccines and therapies, as well as understand the long-term effects of the infection.

From The University of California, Davis 26 Nov 2021

Antibodies play a major role in managing gut mycobiota, says study

According to recent research, antibody protection against harmful forms of fungi in the gut might be disrupted in some patients with Crohn’s disease.

25 Nov 2021

Research details how HIV-infected cells evade detection by the immune system

Scientists from the Wistar Institute revealed how major features on the surface of HIV-infected cells help the disease avoid detection by the immune system.

15 Nov 2021

Immune system–related differences in dialysis, kidney transplant patients are amplified by SARS-CoV-2

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

8 Nov 2021

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from researchers at the University of California, Davis.

From The University of California, Davis 2 Nov 2021

New approach to cut off cancer cells’ food supply and kill them

Inositol is a sugar required for cells to survive. Most cells either get it from the bloodstream or make it themselves. Since there is plenty of inositol available, some cancer cells decide to stop making it.

28 Oct 2021

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics announced today that it has closed a $40 million (circa £30 million) investment round.

From Sphere Fluidics Limited 28 Oct 2021

Low dose of pollutants in food leads to high activation of antibodies that cause allergic response

Exposure to the heavy metal cadmium is known to irritate the stomach and lungs or cause kidney disease, but new research links another health issue to inadvertently ingesting low doses of the pollutant: high activation of the antibodies that cause an allergic response.

27 Oct 2021

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response.

27 Oct 2021

Horse hyperimmune antibody may be an efficient approach to combat SARS-CoV-2

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat covid-19.

27 Oct 2021

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

Today bit.bio welcomed three new members to its Board of Directors, who bring their respective experience of turning world-class science into new industries.

From bit.bio 27 Oct 2021

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

Experts develop antibodies that effectively remove senescent cells

The reason why some people age worse than others and develop diseases linked to the aging mechanism is largely unknown.

22 Oct 2021

Study identifies highly potent monoclonal antibody against all SARS-CoV-2 variants

Researchers identified a greatly potent monoclonal antibody that aims at the spike protein of SARS-CoV-2.

19 Oct 2021

Symposium highlights the science gaps for risk assessment of PFAS in food

Developing ways to measure and study exposures to a class of synthetic chemicals is critical to addressing potential health risks stemming from a long history of consumer uses in food wrappers, popcorn bags and paperboard.

12 Oct 2021

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

Multi-institutional researchers have succeeded in efficiently delivering an immune checkpoint inhibitor (ICI) into the mouse brain, confirming its high efficacy and specificity in treating orthotopically transplanted mice with glioblastoma (GBM). The research was published in Nature Biomedical Engineering.

12 Oct 2021

Antibody News and Research

Further Reading

Anti-idiotype antibodies may explain the long-term effects of COVID-19

Antibodies play a major role in managing gut mycobiota, says study

Research details how HIV-infected cells evade detection by the immune system

Immune system–related differences in dialysis, kidney transplant patients are amplified by SARS-CoV-2

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

New approach to cut off cancer cells’ food supply and kill them

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Low dose of pollutants in food leads to high activation of antibodies that cause allergic response

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Horse hyperimmune antibody may be an efficient approach to combat SARS-CoV-2

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

Experts develop antibodies that effectively remove senescent cells

Study identifies highly potent monoclonal antibody against all SARS-CoV-2 variants

Symposium highlights the science gaps for risk assessment of PFAS in food

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

Low antibody response against SARS-CoV-2 predicts increased mortality

Active genes do not form clusters and share resources during early development in fruit flies

Fully vaccinated people who had COVID-19 end up with larger number of memory B cells

Novel Assay Platform for 3D Microfluidic Cancer Research

Antibodies eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics